US Stock MarketDetailed Quotes

ASMB Assembly Biosciences

Watchlist
  • 15.275
  • +0.145+0.96%
Trading Jul 22 14:32 ET
96.93MMarket Cap-1443P/E (TTM)

Assembly Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
5.79M
7.16M
7.16M
0
0
0
0
0
0
0
Operating revenue
--5.79M
--7.16M
--7.16M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.57%16.51M
-23.70%71.81M
-14.20%19.71M
-35.70%15.05M
-28.83%17.49M
-15.56%19.56M
-3.28%94.11M
8.13%22.98M
-6.88%23.4M
3.83%24.57M
Selling and administrative expenses
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-19.86%4.22M
-26.78%4.97M
-15.86%5.01M
-16.14%24.13M
-5.83%6.13M
-20.80%5.27M
-1.97%6.78M
-General and administrative expense
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-19.86%4.22M
-26.78%4.97M
-15.86%5.01M
-16.14%24.13M
-5.83%6.13M
-20.80%5.27M
-1.97%6.78M
Research and development costs
-18.34%11.88M
-30.12%48.9M
-34.69%11.01M
-40.30%10.82M
-29.61%12.52M
-15.45%14.55M
2.12%69.98M
14.28%16.85M
-1.86%18.13M
6.23%17.79M
Operating profit
45.15%-10.73M
31.31%-64.65M
45.38%-12.55M
35.70%-15.05M
28.83%-17.49M
15.56%-19.56M
-3.37%-94.11M
-8.13%-22.98M
-23.98%-23.4M
-3.83%-24.57M
Net non-operating interest income expense
171.26%1.65M
237.67%3.45M
178.22%1.62M
145.31%628K
428.57%592K
757.75%609K
238.41%1.02M
477.23%583K
255.56%256K
57.75%112K
Non-operating interest income
171.26%1.65M
237.67%3.45M
178.22%1.62M
145.31%628K
428.57%592K
757.75%609K
238.41%1.02M
477.23%583K
255.56%256K
57.75%112K
Other net income (expense)
Income before tax
52.10%-9.08M
34.26%-61.2M
51.20%-10.93M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
29.68%-93.09M
64.33%-22.4M
-23.09%-23.15M
-3.67%-24.46M
Income tax
33K
0
Net income
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
-3.67%-24.46M
Net income continuous Operations
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
-3.67%-24.46M
Minority interest income
Net income attributable to the parent company
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
-3.67%-24.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
-3.67%-24.46M
Basic earnings per share
62.78%-1.66
42.03%-13.38
68.71%-1.74
43.75%-3.24
37.25%-3.84
22.57%-4.46
35.89%-23.08
66.18%-5.56
-17.07%-5.76
7.27%-6.12
Diluted earnings per share
62.78%-1.66
42.03%-13.38
68.71%-1.74
43.75%-3.24
37.25%-3.84
22.57%-4.46
35.89%-23.08
66.18%-5.56
-17.07%-5.76
7.27%-6.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 5.79M7.16M7.16M0000000
Operating revenue --5.79M--7.16M--7.16M--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.57%16.51M-23.70%71.81M-14.20%19.71M-35.70%15.05M-28.83%17.49M-15.56%19.56M-3.28%94.11M8.13%22.98M-6.88%23.4M3.83%24.57M
Selling and administrative expenses -7.52%4.64M-5.08%22.91M42.17%8.71M-19.86%4.22M-26.78%4.97M-15.86%5.01M-16.14%24.13M-5.83%6.13M-20.80%5.27M-1.97%6.78M
-General and administrative expense -7.52%4.64M-5.08%22.91M42.17%8.71M-19.86%4.22M-26.78%4.97M-15.86%5.01M-16.14%24.13M-5.83%6.13M-20.80%5.27M-1.97%6.78M
Research and development costs -18.34%11.88M-30.12%48.9M-34.69%11.01M-40.30%10.82M-29.61%12.52M-15.45%14.55M2.12%69.98M14.28%16.85M-1.86%18.13M6.23%17.79M
Operating profit 45.15%-10.73M31.31%-64.65M45.38%-12.55M35.70%-15.05M28.83%-17.49M15.56%-19.56M-3.37%-94.11M-8.13%-22.98M-23.98%-23.4M-3.83%-24.57M
Net non-operating interest income expense 171.26%1.65M237.67%3.45M178.22%1.62M145.31%628K428.57%592K757.75%609K238.41%1.02M477.23%583K255.56%256K57.75%112K
Non-operating interest income 171.26%1.65M237.67%3.45M178.22%1.62M145.31%628K428.57%592K757.75%609K238.41%1.02M477.23%583K255.56%256K57.75%112K
Other net income (expense)
Income before tax 52.10%-9.08M34.26%-61.2M51.20%-10.93M37.70%-14.42M30.93%-16.9M17.93%-18.95M29.68%-93.09M64.33%-22.4M-23.09%-23.15M-3.67%-24.46M
Income tax 33K0
Net income 52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M-3.67%-24.46M
Net income continuous Operations 52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M-3.67%-24.46M
Minority interest income
Net income attributable to the parent company 52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M-3.67%-24.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M-3.67%-24.46M
Basic earnings per share 62.78%-1.6642.03%-13.3868.71%-1.7443.75%-3.2437.25%-3.8422.57%-4.4635.89%-23.0866.18%-5.56-17.07%-5.767.27%-6.12
Diluted earnings per share 62.78%-1.6642.03%-13.3868.71%-1.7443.75%-3.2437.25%-3.8422.57%-4.4635.89%-23.0866.18%-5.56-17.07%-5.767.27%-6.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg